Among the most popular fund investment industries, there are Medical, Health Care. Among the most popular portfolio startups of the fund, we may highlight Eligo Bioscience. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Worldwide Innovation Challenge, startups are often financed by Seventure Partners, Khosla Ventures, AGORANOV. The meaningful sponsors for the fund in investment in the same round are Seventure Partners. In the next rounds fund is usually obtained by Seventure Partners, Khosla Ventures, EASME - EU Executive Agency for SMEs.
Deals in the range of 1 - 5 millions dollars are the general things for fund. The high activity for fund was in 2015. The fund is constantly included in less than 2 investment rounds annually.
Related Funds
| Fund Name | Location |
| 21 Invest | France, Ile-de-France, Paris |
| eGuarantee | Japan, Tokyo |
| European Social Fund (ESF) | - |
| Growth Partners | Cleveland, Ohio, United States |
| GRT Capital Partners | Boston, Massachusetts, United States |
| Hidragon Capital | China, Shanghai |
| ICBA ThinkTECH Accelerator 2.0 | Arkansas, Little Rock, United States |
| IMJ Investment Partners | - |
| Indian Dream Capital | - |
| Jixin Enterprise Management Consulting | China, Shanghai |
| Librae Holdings | - |
| Martal Capital | Canada, Oakville, Ontario |
| NBD Ventures | China, Hong Kong, Hong Kong Island |
| Nedamco Capital | Bloemendaal, Noord-Holland, The Netherlands |
| Nesta | England, London, United Kingdom |
| Stanford Management | Maine, Portland, United States |
| Tiesto | - |
| United Internet Ventures | Germany, Rheinland-Pfalz, Rhineland-Palatinate |
| Veneto Sviluppo | Italy, Marghera, Veneto |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Eligo Bioscience | $3M | 09 Jul 2015 | Paris, Ile-de-France, France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Eligo Bioscience | $3M | 09 Jul 2015 | Paris, Ile-de-France, France |
